000 | 00943nam a2200145Ia 4500 | ||
---|---|---|---|
008 | 220515s9999||||xx |||||||||||||| ||und|| | ||
050 | _aW 22.1 .W56 2004 | ||
110 | _aWorld Health Organization | ||
245 | 0 | _aWHO Medicines Strategy: countries at the core 2004-2007 | |
260 |
_aGeneva _bWorld Health Organization _c2004 |
||
300 | _axii, 150p. | ||
500 | _aThe WHO Medicines Strategy 2004-2007 was developed by the World Health Organization (WHO) country, regional, and headquarters staff working in essential drugs and medicines policy, in consultation with other WHO programmes and key development partners. This Strategy is basically an update of the WHO Medicines Strategy 2000-2003. Discusses several issues such as the challenge of meeting essential medicine needs, components of the strategy, working in line with WHO Strategy and examining progress. | ||
650 | _aDrugs, Essential|Medicine|World Health Organization | ||
942 |
_2lcc _cBK |
||
999 |
_c284 _d284 |